STERIS plc Stock price

Equities

STE

IE00BFY8C754

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:02 2024-03-28 pm EDT 5-day change 1st Jan Change
224.8 USD -0.31% Intraday chart for STERIS plc -1.00% +2.26%
Sales 2024 * 5.47B Sales 2025 * 5.83B Capitalization 22.22B
Net income 2024 * 544M Net income 2025 * 652M EV / Sales 2024 * 4.6 x
Net Debt 2024 * 2.94B Net Debt 2025 * 2.41B EV / Sales 2025 * 4.22 x
P/E ratio 2024 *
41.1 x
P/E ratio 2025 *
32.9 x
Employees 17,000
Yield 2024 *
0.9%
Yield 2025 *
0.99%
Free-Float 99.73%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.31%
1 week-1.00%
Current month-3.47%
1 month-2.82%
3 months+1.39%
6 months+1.18%
Current year+2.26%
More quotes
1 week
219.50
Extreme 219.5
228.93
1 month
219.50
Extreme 219.5
235.04
Current year
210.00
Extreme 210
238.51
1 year
180.54
Extreme 180.54
254.00
3 years
159.21
Extreme 159.21
255.93
5 years
105.69
Extreme 105.69
255.93
10 years
47.22
Extreme 47.22
255.93
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 18-07-31
Director of Finance/CFO 56 14-01-31
Investor Relations Contact - 04-04-30
Members of the board TitleAgeSince
Director/Board Member 74 08-03-31
Director/Board Member 74 03-09-30
Director/Board Member 58 20-07-27
More insiders
Date Price Change Volume
24-03-28 224.8 -0.31% 497,538
24-03-27 225.5 +1.81% 467,410
24-03-26 221.5 +0.39% 509,847
24-03-25 220.7 -3.64% 696,551
24-03-22 229 +0.84% 623,932

Delayed Quote Nyse, March 28, 2024 at 04:00 pm EDT

More quotes
STERIS plc is one of the world's leading providers of infection control solutions and procedural services. Net sales break down by activity as follows: - sales of infection control solutions (62.9%): including cleaning and sterilization chemicals, accessories for gastrointestinal procedures, washers, sterilizers and operating room equipment (including surgical tables, lighting and connectivity solutions). In addition, the group offers specialized healthcare services (sterilization services, instrument and endoscope repair and maintenance and customized process improvement consulting in acute care hospitals); - development of applied sterilization solutions (22.1%): contract development of sterilization modalities and laboratory testing services for more than 50 sterilization and laboratory facilities worldwide; - manufacturing of consumables and maintenance equipment (15%): dedicated to pharmaceutical manufacturers. Net sales by source of income are divided into sales of services (53.5%), sales of consumables (23.4%) and sales of equipment (23.1%). Net sales are distributed geographically as follows Ireland (2.3%), the United States (71.7%) and other (26%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
224.8 USD
Average target price
239.9 USD
Spread / Average Target
+6.69%
Consensus
  1. Stock
  2. Equities
  3. Stock STERIS plc - Nyse